CareDx, Inc. (CDNA) vs RadNet, Inc. (RDNT)

CareDx, Inc. and RadNet, Inc. are both Diagnostics & Research companies. RadNet, Inc. is the larger, with a market value of $6.1B against $4.0B — 1.5× the size. RadNet, Inc. has negative trailing earnings, so its P/E is not meaningful; CareDx, Inc. trades at 30.9×. CareDx, Inc. grew revenue faster over the last twelve months: 38.9% against 18.9%. CareDx, Inc. has the higher net margin (25.9% vs −0.93%) and the higher return on invested capital (33.6% vs 2.24%). Across the 20 metrics below, CareDx, Inc. leads on 15 and RadNet, Inc. on 5.

Valuation

Metric CDNA RDNT Diagnostics & Research median
P/E 30.91 n/m 34.52
P/S 8.06 2.69 4.24
P/B 8.58 4.38 3.42
Price to free cash flow 68.93 188.87 33.51
EV/EBITDA 26.62 21.80 23.44
EV/Sales 7.57 2.96 5.18
Earnings yield 3.24% (0.34%) (1.50%)
Free cash flow yield 1.45% 0.53% 0.00%

Profitability

Metric CDNA RDNT Diagnostics & Research median
Gross margin 70.97% 11.53% 48.32%
Operating margin 23.42% 3.12% (5.68%)
Net margin 25.86% (0.93%) (4.10%)
Free cash flow margin 12.01% 3.28% 0.00%
Return on equity 33.04% (1.64%) 0.00%
Return on assets 23.96% (0.55%) (6.05%)
Return on invested capital 33.56% 2.24% 0.00%

Growth

Metric CDNA RDNT Diagnostics & Research median
Revenue growth (TTM) 38.94% 18.92% 8.99%
EPS growth (last fiscal year) (143.01%) (725.00%) 20.36%
Revenue growth, 5-year CAGR 14.59% 13.74% 7.30%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CDNA RDNT Diagnostics & Research median
Debt to equity 0.00 0.94 0.01
Current ratio 2.31 1.48 2.27
Net debt to EBITDA 19.49 1.16 0.68

Dividend

Metric CDNA RDNT Diagnostics & Research median
Dividend yield — — 0.67%
Payout ratio — — 0.20

Size

Metric CDNA RDNT Diagnostics & Research median
Market cap 4.01b 6.14b 2.22b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack